-
1
-
-
36549034768
-
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths
-
Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 2007, 370:1829-1839.
-
(2007)
Lancet
, vol.370
, pp. 1829-1839
-
-
Lewington, S.1
Whitlock, G.2
Clarke, R.3
-
2
-
-
70450081001
-
Major lipids, apolipoproteins, and risk of vascular disease
-
Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009, 302:1993-2000.
-
(2009)
JAMA
, vol.302
, pp. 1993-2000
-
-
Di Angelantonio, E.1
Sarwar, N.2
Perry, P.3
-
3
-
-
0025322265
-
Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit
-
Badimon JJ, Badimon L, Fuster V Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest 1990, 85:1234-1241.
-
(1990)
J Clin Invest
, vol.85
, pp. 1234-1241
-
-
Badimon, J.J.1
Badimon, L.2
Fuster, V.3
-
4
-
-
0032706442
-
Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice
-
Tangirala RK, Tsukamoto K, Chun SH, Usher D, Pure E, Rader DJ Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation 1999, 100:1816-1822.
-
(1999)
Circulation
, vol.100
, pp. 1816-1822
-
-
Tangirala, R.K.1
Tsukamoto, K.2
Chun, S.H.3
Usher, D.4
Pure, E.5
Rader, D.J.6
-
5
-
-
36348975228
-
Effects of torcetrapib in patients at high risk for coronary events
-
Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007, 357:2109-2122.
-
(2007)
N Engl J Med
, vol.357
, pp. 2109-2122
-
-
Barter, P.J.1
Caulfield, M.2
Eriksson, M.3
-
6
-
-
84870045994
-
Effects of dalcetrapib in patients with a recent acute coronary syndrome
-
Schwartz GG, Olsson AG, Abt M, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012, 367:2089-2099.
-
(2012)
N Engl J Med
, vol.367
, pp. 2089-2099
-
-
Schwartz, G.G.1
Olsson, A.G.2
Abt, M.3
-
7
-
-
84855171302
-
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy
-
Boden WE, Probstfield JL, Anderson T, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011, 365:2255-2267.
-
(2011)
N Engl J Med
, vol.365
, pp. 2255-2267
-
-
Boden, W.E.1
Probstfield, J.L.2
Anderson, T.3
-
8
-
-
84904252744
-
Effects of extended-release niacin with laropiprant in high-risk patients
-
HPS2-THRIVE Collaborative Group
-
Landray MJ, Haynes R Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014, 371:203-212. HPS2-THRIVE Collaborative Group.
-
(2014)
N Engl J Med
, vol.371
, pp. 203-212
-
-
Landray, M.J.1
Haynes, R.2
-
9
-
-
44649140474
-
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease
-
Frikke-Schmidt R, Nordestgaard BG, Stene MC, et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 2008, 299:2524-2532.
-
(2008)
JAMA
, vol.299
, pp. 2524-2532
-
-
Frikke-Schmidt, R.1
Nordestgaard, B.G.2
Stene, M.C.3
-
10
-
-
84864845456
-
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
-
Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012, 380:572-580.
-
(2012)
Lancet
, vol.380
, pp. 572-580
-
-
Voight, B.F.1
Peloso, G.M.2
Orho-Melander, M.3
-
11
-
-
0032945240
-
Cell cholesterol efflux: integration of old and new observations provides new insights
-
Rothblat GH, de la Llera-Moya M, Atger V, Kellner-Weibel G, Williams DL, Phillips MC Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 1999, 40:781-796.
-
(1999)
J Lipid Res
, vol.40
, pp. 781-796
-
-
Rothblat, G.H.1
de la Llera-Moya, M.2
Atger, V.3
Kellner-Weibel, G.4
Williams, D.L.5
Phillips, M.C.6
-
12
-
-
78651379500
-
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
-
Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011, 364:127-135.
-
(2011)
N Engl J Med
, vol.364
, pp. 127-135
-
-
Khera, A.V.1
Cuchel, M.2
de la Llera-Moya, M.3
-
13
-
-
67649877665
-
The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls
-
Parish S, Peto R, Palmer A, et al. The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls. Eur Heart J 2009, 30:2137-2146.
-
(2009)
Eur Heart J
, vol.30
, pp. 2137-2146
-
-
Parish, S.1
Peto, R.2
Palmer, A.3
-
14
-
-
84879113852
-
Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks
-
Li XM, Tang WH, Mosior MK, et al. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks. Arterioscler Thromb Vasc Biol 2013, 33:1696-1705.
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, pp. 1696-1705
-
-
Li, X.M.1
Tang, W.H.2
Mosior, M.K.3
-
15
-
-
84919343998
-
HDL Cholesterol efflux capacity and incident cardiovascular events
-
Rohatgi A, Khera A, Berry JD, et al. HDL Cholesterol efflux capacity and incident cardiovascular events. N Engl J Med 2014, 371:2383-2393.
-
(2014)
N Engl J Med
, vol.371
, pp. 2383-2393
-
-
Rohatgi, A.1
Khera, A.2
Berry, J.D.3
-
16
-
-
0032795012
-
EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer
-
Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999, 80(suppl 1):95-103.
-
(1999)
Br J Cancer
, vol.80
, pp. 95-103
-
-
Day, N.1
Oakes, S.2
Luben, R.3
-
17
-
-
4544230882
-
Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study
-
Boekholdt SM, Kuivenhoven JA, Wareham NJ, et al. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study. Circulation 2004, 110:1418-1423.
-
(2004)
Circulation
, vol.110
, pp. 1418-1423
-
-
Boekholdt, S.M.1
Kuivenhoven, J.A.2
Wareham, N.J.3
-
18
-
-
84934447360
-
-
(accessed May 15, 2015).
-
ICD-9-CM Official Guidelines for Coding and Reporting, (accessed May 15, 2015). http://www.cdc.gov/nchs/data/icd/icd9cm_guidelines_2011.pdf.
-
-
-
-
19
-
-
77950894330
-
The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages
-
de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Cuchel M, Rader DJ, Rothblat GH The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol 2010, 30:796-801.
-
(2010)
Arterioscler Thromb Vasc Biol
, vol.30
, pp. 796-801
-
-
de la Llera-Moya, M.1
Drazul-Schrader, D.2
Asztalos, B.F.3
Cuchel, M.4
Rader, D.J.5
Rothblat, G.H.6
-
20
-
-
0025893209
-
Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group
-
Easton DF, Peto J, Babiker AG Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 1991, 10:1025-1035.
-
(1991)
Stat Med
, vol.10
, pp. 1025-1035
-
-
Easton, D.F.1
Peto, J.2
Babiker, A.G.3
-
21
-
-
81855206679
-
A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol
-
Sankaranarayanan S, Kellner-Weibel G, de la Llera-Moya M, et al. A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol. J Lipid Res 2011, 52:2332-2340.
-
(2011)
J Lipid Res
, vol.52
, pp. 2332-2340
-
-
Sankaranarayanan, S.1
Kellner-Weibel, G.2
de la Llera-Moya, M.3
|